Literature DB >> 20310013

Nonfistulizing perianal Crohn's disease: clinical features, epidemiology, and treatment.

Guillaume Bouguen1, Laurent Siproudhis, Jean-François Bretagne, Marc-André Bigard, Laurent Peyrin-Biroulet.   

Abstract

Nonfistulizing perianal lesions, including ulcerations, strictures, and anal carcinoma, are frequently observed in Crohn's disease. Their clinical course remains poorly known. The management of these lesions is difficult because none of the treatments used is evidence-based. Ulcerations may be symptomatic in up to 85% of patients. Most ulcerations heal spontaneously but may also progress to anal stenosis or fistula/abscess. Topical treatments only improve symptoms, while complete healing can occur in patients with perianal ulcerations receiving infliximab therapy. Half of all patients with anal strictures will require permanent fecal diversion. Dilatation for symptomatic strictures should be performed on a highly selective basis in the absence of active rectal disease in order to avoid infectious complications. Anorectal strictures associated with rectal lesions should first be managed with medical therapy. Skin tags are usually painless and may hide other perianal lesions. Anal cancer is uncommon. Its treatment is similar to that recommended for anal cancer occurring in non-Crohn's disease patients. After reviewing the classification, clinical features, and epidemiology of each type of nonfistulizing perianal lesion (ulceration, stricture, skin tags, and anal cancer), we discuss the efficacy of medical treatment and surgery. This review article may help physicians in decision-making when managing potentially disabling lesions.

Entities:  

Mesh:

Year:  2010        PMID: 20310013     DOI: 10.1002/ibd.21261

Source DB:  PubMed          Journal:  Inflamm Bowel Dis        ISSN: 1078-0998            Impact factor:   5.325


  14 in total

1.  Crohn's disease: is there any link between anal and luminal phenotypes?

Authors:  Timothée Wallenhorst; Charlène Brochard; Jean-François Bretagne; Guillaume Bouguen; Laurent Siproudhis
Journal:  Int J Colorectal Dis       Date:  2015-09-26       Impact factor: 2.571

2.  Perianal Crohn's disease findings other than fistulas in a population-based cohort.

Authors:  Laurent Peyrin-Biroulet; Edward V Loftus; William J Tremaine; W Scott Harmsen; Alan R Zinsmeister; William J Sandborn
Journal:  Inflamm Bowel Dis       Date:  2011-02-23       Impact factor: 5.325

3.  Evaluation of diagnostic criteria for Crohn's disease in Japan.

Authors:  Takashi Hisabe; Fumihito Hirai; Toshiyuki Matsui; Mamoru Watanabe
Journal:  J Gastroenterol       Date:  2013-04-03       Impact factor: 7.527

Review 4.  Pharmacological Approach to the Management of Crohn's Disease Patients with Perianal Disease.

Authors:  Fernando Bermejo; Iván Guerra; Alicia Algaba; Antonio López-Sanromán
Journal:  Drugs       Date:  2018-01       Impact factor: 9.546

Review 5.  Multidisciplinary management of gastrointestinal fibrotic stenosis in Crohn's disease.

Authors:  Brice Malgras; Karine Pautrat; Xavier Dray; Pierre Pasquier; Patrice Valleur; Marc Pocard; Philippe Soyer
Journal:  Dig Dis Sci       Date:  2014-11-08       Impact factor: 3.199

Review 6.  Differential diagnosis in inflammatory bowel disease colitis: state of the art and future perspectives.

Authors:  Gian Eugenio Tontini; Maurizio Vecchi; Luca Pastorelli; Markus F Neurath; Helmut Neumann
Journal:  World J Gastroenterol       Date:  2015-01-07       Impact factor: 5.742

Review 7.  Anorectal Strictures in Complex Perianal CD: How to Approach?

Authors:  Amy L Lightner; Miguel Regueiro
Journal:  Clin Colon Rectal Surg       Date:  2022-01-17

8.  Hyperbaric oxygen treatment for inflammatory bowel disease: a systematic review and analysis.

Authors:  Daniel A Rossignol
Journal:  Med Gas Res       Date:  2012-03-15

Review 9.  Role of magnetic resonance imaging in the management of perianal Crohn's disease.

Authors:  Jose C Gallego; Ana Echarri
Journal:  Insights Imaging       Date:  2017-11-15

10.  Defining and predicting deep remission in patients with perianal fistulizing Crohn's disease on anti-tumor necrosis factor therapy.

Authors:  Konstantinos Papamichael; Adam S Cheifetz
Journal:  World J Gastroenterol       Date:  2017-09-14       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.